Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Martha (muffy) Carter

Chief Regulatory Officer
Life Science
United States of America


Martha (Muffy) Carter joined Albireo in November 2016. Muffy has four decades of regulatory experience in the biopharmaceutical industry. Most recently, Muffy was Chief Regulatory Officer and Senior Vice President of Aegerion Pharmaceuticals, a biopharmaceutical company focused in rare diseases, where she established global regulatory and quality functions and played a key role in bringing JUXTAPID®/LOJUXTA® (lomitapide) for the treatment of homozygous familial hypercholesterolemia to market in 36 countries. Prior to Aegerion, she served as Senior Vice President and Chief Regulatory Officer at Proteon Therapeutics and Senior Vice President, Regulatory Affairs at Trine Pharmaceuticals. Earlier in her career, Muffy held various positions of increasing responsibility in regulatory affairs, strategic planning and compliance. She has authored or co-authored numerous publications on regulatory matters and professional ethics. Muffy holds a B.A. in biology from Northeastern University. 

Research Interest

Bile Acids and IBAT Inhibition 

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences
View more